PT Charlie Hospital Semarang Tbk (ISX:RSCH) Research & Development: Rp Mil (TTM As of . 20)


What is PT Charlie Hospital Semarang Tbk Research & Development?

PT Charlie Hospital Semarang Tbk ISX:RSCH +7.63% Research & Development is Rp Mil as of . 20. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PT Charlie Hospital Semarang Tbk's Research & Development for the six months ended in . 20 was Rp0.00 Mil. PT Charlie Hospital Semarang Tbk does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

PT Charlie Hospital Semarang Tbk  (ISX:RSCH) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PT Charlie Hospital Semarang Tbk Research & Development Related Terms

PT Charlie Hospital Semarang Tbk Research & Development Historical Data

* Premium members only.

The historical data trend for PT Charlie Hospital Semarang Tbk's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Charlie Hospital Semarang Tbk Research & Development Chart

PT Charlie Hospital Semarang Tbk Annual Data
Trend
Research & Development

PT Charlie Hospital Semarang Tbk Semi-Annual Data
Research & Development

PT Charlie Hospital Semarang Tbk Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of Rp Mil mean?
PT Charlie Hospital Semarang Tbk (ISX:RSCH) has a Research & Development of Rp Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on PT Charlie Hospital Semarang Tbk and its competitors.
Is PT Charlie Hospital Semarang Tbk's Research & Development too high?
PT Charlie Hospital Semarang Tbk's current Research & Development is Rp Mil.
How does PT Charlie Hospital Semarang Tbk's Research & Development compare to HCA and THC?
PT Charlie Hospital Semarang Tbk's Research & Development of Rp Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PT Charlie Hospital Semarang Tbk and its competitors. PT Charlie Hospital Semarang Tbk's current Research & Development is Rp Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Charlie Hospital Semarang Tbk stock overvalued right now?
PT Charlie Hospital Semarang Tbk (ISX:RSCH) has a current Research & Development of Rp Mil. The current Research & Development is Rp Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PT Charlie Hospital Semarang Tbk (ISX:RSCH), the current Research & Development is Rp Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Charlie Hospital Semarang Tbk Business Description

Address Raya Ngabean Road, Lot 1A, Ngabean Village, Boja District, Kendal Regency, Central Java, Jawa, IDN, 51381
PT Charlie Hospital Semarang Tbk is engaged in private hospital activities with type D hospital qualifications located in Kendal Regency. It provides medical facilities, such as a 24-hour emergency room, Specialist Polyclinic services, Central Surgical Installation, Intensive Care Unit (ICU), Perina, Laboratory, Radiology, Pharmacy, and other supporting facilities. It operates in three segments, namely Hospital service consist of medical goods and services provided to out patients and inpatients. Construction materials trading and Construction activities include services rendered on a fee or contract basis, as well as the construction, maintenance, or reconstruction of residential, office, industrial, commercial, healthcare, educational, lodging, entertainment/sports, and other buildings.